A diagnosis of MASH (metabolic dysfunction-associated steatohepatitis) brings enough stress on its own. High out-of-pocket healthcare costs should not add to that burden. The FDA approved the brand-name drug Rezdiffra (Resmetirom 80 mg) in March 2024. Today, it retails for…
Vitiligo is a skin condition that affects millions worldwide. It causes patches of skin to lose their color. This can lead to significant emotional and psychological distress. Recent advancements in treatment offer new hope. Jak inhibitors, a class of medication,…
Eczema scars can be a persistent reminder of past flare-ups. Many people seek natural ways to heal these scars and to heal eczema scars without harsh products. Natural remedies offer a gentle approach to skin care with practical scar removal…
Vitiligo is a skin condition that affects millions worldwide. It causes patches of skin to lose their color. This can lead to noticeable white spots on various parts of the body. For those living with vitiligo, finding effective treatment is…
Medically Reviewed by: Dr. Salma Elreedy, Clinical Oncologist, Sphinx Cure Oncology Center. Fact-Checked by: Generic Oncology Editorial Team. Synthetic lethality is a genetic phenomenon where the simultaneous loss of function in two separate genes results in cell death, while the…
Protocol Overview Historically, the discipline of clinical oncology maintained a singular, aggressive focus on tumor eradication. The primary metric of success was the reduction of tumor burden, often at the severe expense of the patient’s physical and psychological tolerance. Today,…
We have moved beyond the era where cancer care was defined strictly by high-cost, exclusive branded drugs accessible only to a small percentage of the global population. Today, the focus has shifted toward the democratization of treatment through scientific advancement…
The financial burden of cancer medication costs is often described by the medical community as “Financial Toxicity.” This is not just a term for high bills; it is a clinical reality that affects how well a patient recovers. When the…
In the year 2026, the global oncology market is saturated with options. While the availability of generic medications has made cancer treatment more affordable, it has also introduced a critical challenge for patients and healthcare providers: how to distinguish a…
